{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:46:39Z","timestamp":1781016399360,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chanchlani Research Centre"},{"name":"Peter Boris Centre for Addictions Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13643-016-0317-2","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T13:29:45Z","timestamp":1471354185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol"],"prefix":"10.1186","volume":"5","author":[{"given":"Laura","family":"Zielinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"McDermid Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"317_CR1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report. 2016."},{"key":"317_CR2","first-page":"55","volume":"379","author":"L Degenhardt","year":"2012","unstructured":"Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (London, England). Elsevier Ltd. 2012;379:55\u201370.","journal-title":"Elsevier Ltd"},{"key":"317_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jurban\/jti049","volume":"82","author":"B Fischer","year":"2005","unstructured":"Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, El-Guebaly N, et al. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health. 2005;82:250\u201366.","journal-title":"J Urban Health"},{"key":"317_CR4","first-page":"68","volume":"55","author":"B Sproule","year":"2009","unstructured":"Sproule B, Brands B, Li S, Catz-Biro L. Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. Can Fam Physician. 2009;55:68\u20139. e1-5.","journal-title":"Can Fam Physician"},{"key":"317_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/add.12224","volume":"109","author":"B Fischer","year":"2013","unstructured":"Fischer B, Keates A, B\u00fchringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2013;109:177\u201381.","journal-title":"Addiction"},{"key":"317_CR6","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1503\/cmaj.060729","volume":"175","author":"B Fischer","year":"2006","unstructured":"Fischer B, Rehm J, Patra J, Firestone CM. Changes in illicit opioid use across Canada. Can Med Assoc J. 2006;175:1385.","journal-title":"Can Med Assoc J"},{"key":"317_CR7","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst. Rev. 2009; CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"317_CR8","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2014;CD002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"317_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2011.01.008","volume":"117","author":"SM Kelly","year":"2012","unstructured":"Kelly SM, Grady KEO, Mitchell SG, Brown BS, Schwartz RP. Predictors of methadone treatment retention from a multi-site study: a survival analysis. Drug Alcohol Depend. 2012;117:170\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"317_CR10","first-page":"9","volume":"260","author":"JR Roberts","year":"2009","unstructured":"Roberts JR. Methadone maintenance: the basics. Emerg Med News. 2009;260:9\u201311.","journal-title":"Emerg Med News"},{"key":"317_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/02791072.2014.901587","volume":"46","author":"WL White","year":"2014","unstructured":"White WL, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention. J Psychoactive Drugs. 2014;46:114\u201322.","journal-title":"J Psychoactive Drugs"},{"key":"317_CR12","doi-asserted-by":"crossref","unstructured":"Taylor OD. Poly substance use in methadone maintenance therapy (MMT) patients. J. Hum. Behav. Soc. Environ. 2015;25:1\u20138.","DOI":"10.1080\/10911359.2015.1028260"},{"key":"317_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1037\/0893-164X.10.4.222","volume":"10","author":"TD Nirenberg","year":"1996","unstructured":"Nirenberg TD, Cellucci T, Liepman MR, Swift RM, Sirota AD. Cannabis versus other illicit drug use among methadone maintenance patients. Psychol Addict Behav. 1996;10:222\u20137.","journal-title":"Psychol Addict Behav"},{"key":"317_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1521-0391.2013.12044.x","volume":"22","author":"JL Scavone","year":"2013","unstructured":"Scavone JL, Sterling RC, Weinstein SP, Van Bockstaele EJ. Impact of cannabis use during stabilization on methadone maintenance treatment. Am J Addict. 2013;22:344\u201351.","journal-title":"Am J Addict"},{"key":"317_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/ajad.12183","volume":"24","author":"DH Epstein","year":"2015","unstructured":"Epstein DH, Preston KL. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper. Am J Addict. 2015;24:323\u20138.","journal-title":"Am J Addict"},{"key":"317_CR16","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370:2219\u201327.","journal-title":"N Engl J Med"},{"key":"317_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03405515","volume":"100","author":"B Fischer","year":"2009","unstructured":"Fischer B, Rehm J, Hall W. Cannabis use in Canada: the need for a \u201cPublic Health\u201d approach. Can J Public Heal. 2009;100:101\u20134.","journal-title":"Can J Public Heal"},{"key":"317_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"THM Moore","year":"2007","unstructured":"Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319\u201328.","journal-title":"Lancet"},{"key":"317_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1046\/j.1360-0443.2003.00437.x","volume":"98","author":"L Degenhardt","year":"2003","unstructured":"Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98:1493\u2013504.","journal-title":"Addiction"},{"key":"317_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12529-014-9429-z","volume":"22","author":"H Newville","year":"2015","unstructured":"Newville H, Berg KM, Gonzalez JS. The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance. Int J Behav Med. 2015;22:214\u201322.","journal-title":"Int J Behav Med"},{"issue":"Suppl 1","key":"317_CR21","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.drugalcdep.2006.12.013","volume":"88","author":"H-U Wittchen","year":"2007","unstructured":"Wittchen H-U, Fr\u00f6hlich C, Behrendt S, G\u00fcnther A, Rehm J, Zimmermann P, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend. 2007;88 Suppl 1:S60\u201370.","journal-title":"Drug Alcohol Depend"},{"key":"317_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/hup.1048","volume":"24","author":"A Crippa","year":"2009","unstructured":"Crippa A, Waldo A, Mart\u0131 R, Atakan Z, Mcguire P, Fusar-poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol Clin Exp. 2009;24:515\u201323.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"317_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1300\/J374v04n01_05","volume":"4","author":"MD Stein","year":"2008","unstructured":"Stein MD, Anderson BJ, Anthony JL. Social phobia, alcohol, and marijuana use in a methadone-maintained population. J Dual Diagn. 2008;4:75\u201386.","journal-title":"J Dual Diagn"},{"key":"317_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0376-8716(98)00092-1","volume":"52","author":"DA Wasserman","year":"1998","unstructured":"Wasserman DA, Weinstein MG, Havassy BE, Hall SM. Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend. 1998;52:183\u201392.","journal-title":"Drug Alcohol Depend"},{"key":"317_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/09595239996734","volume":"18","author":"D Best","year":"1999","unstructured":"Best D, Gossop M, Greenwood J, Marsden J, Lehmann P, Strang J. Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment. Drug Alcohol Rev. 1999;18:31\u20138.","journal-title":"Drug Alcohol Rev"},{"key":"317_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","volume":"98","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98:269\u201379.","journal-title":"Addiction"},{"key":"317_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1360-0443.1998.9344935.x","volume":"93","author":"AJ Budney","year":"1998","unstructured":"Budney AJ, Bickel WK, Amass L. Marijuana use and treatment outcome among opioid-dependent patients. Addiction. 1998;93:493\u2013503.","journal-title":"Addiction"},{"key":"317_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.drugalcdep.2013.02.030","volume":"132","author":"KP Hill","year":"2013","unstructured":"Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, et al. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug Alcohol Depend Elsevier Ireland Ltd. 2013;132:342\u20135.","journal-title":"Drug Alcohol Depend Elsevier Ireland Ltd"},{"key":"317_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archpsyc.1981.01780330033003","volume":"38","author":"D Simpson","year":"1981","unstructured":"Simpson D. Treatment for drug abuse: follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981;38:875\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"317_CR30","first-page":"139","volume-title":"Handbook. Research Synthesis","author":"R Orwin","year":"1994","unstructured":"Orwin R. Evaluating coding decisions. In: Cooper H, Hedges LV, editors. Handbook. Research Synthesis. New York: Russel Sage Foundation; 1994. p. 139\u201362."},{"key":"317_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139.","journal-title":"Ann Intern Med"},{"key":"317_CR32","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-12.","DOI":"10.1001\/jama.283.15.2008"},{"key":"317_CR33","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2000."},{"key":"317_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-3-45","volume":"3","author":"M Bawor","year":"2014","unstructured":"Bawor M, Dennis BB, Anglin R, Steiner M, Thabane L, Samaan Z. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Syst Rev. 2014;3:1\u20137.","journal-title":"Syst Rev"},{"key":"317_CR35","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ Open. 2011;343:d5928.","journal-title":"BMJ Open"},{"key":"317_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380\u20132.","journal-title":"J Clin Epidemiol"},{"key":"317_CR37","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Internet]. Higgins J, Green S, editors. 2011. Available from: handbook.cochrane.org .\u00a0Accessed 20 Oct 2015."},{"key":"317_CR38","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","volume":"340","author":"X Sun","year":"2010","unstructured":"Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117.","journal-title":"BMJ"},{"key":"317_CR39","unstructured":"Kellogg S. Adolescent and young adult heroin patients : drug use and success in methadone maintenance treatment adolescent and young adult heroin patients : drug use and success. 2015."},{"key":"317_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2011.07.007","volume":"42","author":"BP Smyth","year":"2012","unstructured":"Smyth BP, Fagan J, Kernan K. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. J Subst Abuse Treat. 2012;42:35\u201344.","journal-title":"J Subst Abuse Treat"},{"key":"317_CR41","unstructured":"Rotermann M, Langlois K. Prevalence and correlates of marijuana use in Canada, 2012. 2015."},{"key":"317_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.11.010","volume":"123","author":"S Lev-Ran","year":"2012","unstructured":"Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend Elsevier Ireland Ltd. 2012;123:190\u2013200.","journal-title":"Drug Alcohol Depend Elsevier Ireland Ltd"},{"key":"317_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","volume":"136","author":"ZD Cooper","year":"2014","unstructured":"Cooper ZD, Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend Elsevier Ireland Ltd. 2014;136:85\u201391.","journal-title":"Drug Alcohol Depend Elsevier Ireland Ltd"},{"key":"317_CR44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.addbeh.2006.06.034","volume":"32","author":"UE Ghitza","year":"2007","unstructured":"Ghitza UE, Epstein DH, Preston KL. Nonreporting of cannabis use: predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav. 2007;32:938\u201349.","journal-title":"Addict Behav"},{"key":"317_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1\u20139.","journal-title":"Syst Rev"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0317-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-016-0317-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0317-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0317-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T06:04:20Z","timestamp":1601013860000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-016-0317-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s13643-016-0317-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]},"article-number":"139"}}